Inställningar

Split view

Short keys for navigating in split view

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Dark Mode

Set dark mode to MFN.se

Sound

Plays a notification sound when new press release is published in the current feed

18:32:41 Europe / Stockholm

Svenska | English

BioStock

Alligator Bioscience: BioStock: "Unprecedented" phase II data for Alligator in pancreatic cancer

2024-07-03 11:38:32

Alligator Bioscience continues to post convincing phase II data with cancer immunotherapy mitazalimab in pancreatic cancer. Adding to the positive momentum, the Swedish biotech has announced a financing round of up to 80 million MSEK extending its cash runway to Q1 2025. This is setting the company up in a position of strength for their ongoing partnering discussions. BioStock reached out to Alligator's CEO Søren Bregenholt for a comment on the company's hot streak.

Read the article at biostock.se:

https://www.biostock.se/en/2024/07/unprecedented-phase-ii-data-for-alligator-in-pancreatic-cancer/
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

BioStock

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden